Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark H Pollack

Showing results (191-200 of 205) with videos related to

Pageof 21
Sort By:
The Journal of Clinical Psychiatry|May 3, 2006
Persistent posttraumatic stress disorder following September 11 in patients with bipolar disorderMark H Pollack, Naomi M Simon, Andrea Fagiolini, et al.
Journal of Psychiatric Research|July 3, 2023
Using pre-treatment de novo threat conditioning outcomes to predict treatment response to DCS augmentation of exposure-based CBTRebecca E Lubin, Hayley E Fitzgerald, David Rosenfield, et al.
Journal of Psychiatric Research|October 21, 2006
The association of comorbid anxiety disorders with suicide attempts and suicidal ideation in outpatients with bipolar disorderNaomi M Simon, Alyson K Zalta, Michael W Otto, et al.
BMC Psychiatry|July 29, 2018
Evaluating patterns and predictors of symptom change during a three-week intensive outpatient treatment for veterans with PTSDAlyson K Zalta, Philip Held, Dale L Smith, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 10, 2008
A PET study of tiagabine treatment implicates ventral medial prefrontal cortex in generalized social anxiety disorderKarleyton C Evans, Naomi M Simon, Darin D Dougherty, et al.
The Journal of Clinical Psychiatry|March 20, 2008
Paroxetine CR augmentation for posttraumatic stress disorder refractory to prolonged exposure therapyNaomi M Simon, Kathryn M Connor, Ariel J Lang, et al.
Psychiatry Research|August 18, 2004
White matter hyperintensities in subjects with cocaine and opiate dependence and healthy comparison subjectsIn Kyoon Lyoo, Chris C Streeter, Kyung Heup Ahn, et al.
Journal of Clinical Psychopharmacology|September 7, 2004
Pharmacotherapy for bipolar disorder and comorbid conditions: baseline data from STEP-BDNaomi M Simon, Michael W Otto, Roger D Weiss, et al.
The Journal of Clinical Psychiatry|June 18, 2005
Does recovery from substance use disorder matter in patients with bipolar disorder?Roger D Weiss, Michael J Ostacher, Michael W Otto, et al.
JAMA Network Open|June 5, 2020
Dose Timing of D-Cycloserine to Augment Exposure Therapy for Social Anxiety Disorder: A Randomized Clinical TrialJasper A J Smits, Mark H Pollack, David Rosenfield, et al.
Pageof 21

Showing results (191-200 of 205) with videos related to

Sort By:
Pageof 21
The Journal of Clinical Psychiatry|May 3, 2006
Persistent posttraumatic stress disorder following September 11 in patients with bipolar disorderMark H Pollack, Naomi M Simon, Andrea Fagiolini, et al.
Journal of Psychiatric Research|July 3, 2023
Using pre-treatment de novo threat conditioning outcomes to predict treatment response to DCS augmentation of exposure-based CBTRebecca E Lubin, Hayley E Fitzgerald, David Rosenfield, et al.
Journal of Psychiatric Research|October 21, 2006
The association of comorbid anxiety disorders with suicide attempts and suicidal ideation in outpatients with bipolar disorderNaomi M Simon, Alyson K Zalta, Michael W Otto, et al.
BMC Psychiatry|July 29, 2018
Evaluating patterns and predictors of symptom change during a three-week intensive outpatient treatment for veterans with PTSDAlyson K Zalta, Philip Held, Dale L Smith, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|June 10, 2008
A PET study of tiagabine treatment implicates ventral medial prefrontal cortex in generalized social anxiety disorderKarleyton C Evans, Naomi M Simon, Darin D Dougherty, et al.
The Journal of Clinical Psychiatry|March 20, 2008
Paroxetine CR augmentation for posttraumatic stress disorder refractory to prolonged exposure therapyNaomi M Simon, Kathryn M Connor, Ariel J Lang, et al.
Psychiatry Research|August 18, 2004
White matter hyperintensities in subjects with cocaine and opiate dependence and healthy comparison subjectsIn Kyoon Lyoo, Chris C Streeter, Kyung Heup Ahn, et al.
Journal of Clinical Psychopharmacology|September 7, 2004
Pharmacotherapy for bipolar disorder and comorbid conditions: baseline data from STEP-BDNaomi M Simon, Michael W Otto, Roger D Weiss, et al.
The Journal of Clinical Psychiatry|June 18, 2005
Does recovery from substance use disorder matter in patients with bipolar disorder?Roger D Weiss, Michael J Ostacher, Michael W Otto, et al.
JAMA Network Open|June 5, 2020
Dose Timing of D-Cycloserine to Augment Exposure Therapy for Social Anxiety Disorder: A Randomized Clinical TrialJasper A J Smits, Mark H Pollack, David Rosenfield, et al.
Pageof 21